Who
Julie Fuller
Executive Vice President
Company insider
Files Form 4 as: Executive Vice President, Zoetis; Chief People Officer, Pvh.
In numbers
- Trades disclosed
- 50
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $2.0M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 5 Apr 2021
- Last trade
- 9 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Oct 2026filed 13 Oct 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $9,625367.788 at $26.17 | filing |
| 30 Sep 2026filed 2 Oct 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —799 | filing |
| 30 Sep 2026filed 2 Oct 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $19K274 at $69.83 | filing |
| 30 Sep 2026filed 2 Oct 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —799.071 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,250314.645 at $26.22 | filing |
| 10 Jul 2026filed 14 Jul 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $8,250314.65 at $26.22 | filing |
| 10 Apr 2026filed 13 Apr 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $22K550.644 at $39.64 | filing |
| 10 Apr 2026filed 13 Apr 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $22K550.64 at $39.64 | filing |
| 27 Mar 2026filed 31 Mar 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $26K669.337 at $38.20 | filing |
| 27 Mar 2026filed 31 Mar 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $26K669.34 at $38.20 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —750 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $37K290 at $127.28 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —750.426 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code M | —750.43 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code M | —750 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ZTS ZoetisPharmaceuticals | SEC FORM 4 Code F | $37K290 at $127.28 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —3,626 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —14,345 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —3,626 at $0.00 | filing |
| 18 Feb 2026filed 19 Feb 2026 | ZTS Zoetisoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —14,345 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.